Preventing false discovery of heterogeneous treatment effect subgroups in randomized trials
ConclusionsCovariate imbalances may be producing false positives in subgroup analyses. mCART could be a useful tool to help prevent the false discovery of HTE subgroups in secondary analyses of randomized trial data.
Source: Trials - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Cardiology | Cardiovascular | Heart | Learning | Research | Universities & Medical Training